Balyasny Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Buy |
34,500
+7,285
| +27% | +$2.2M | 0.02% | 685 |
|
|
2025
Q1 | $9.01M | Buy |
27,215
+12,987
| +91% | +$4.3M | 0.01% | 684 |
|
|
2024
Q4 | $4.39M | Buy |
+14,228
| New | +$4.39M | 0.01% | 897 |
|
|
2024
Q3 | – | Sell |
-2,448
| Closed | -$686K | – | 2202 |
|
|
2024
Q2 | $686K | Buy |
+2,448
| New | +$686K | ﹤0.01% | 1358 |
|
|
2023
Q4 | – | Sell |
-28,204
| Closed | -$4.12M | – | 2131 |
|
|
2023
Q3 | $4.12M | Buy |
+28,204
| New | +$4.12M | 0.01% | 829 |
|
|
2023
Q1 | – | Sell |
-200
| Closed | -$58.1K | – | 2467 |
|
|
2022
Q4 | $58.1K | Buy |
+200
| New | +$58.1K | ﹤0.01% | 1888 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1411 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1451 |
|